Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
銘柄名/コード:
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/0321 : 02GlobeNewswire Inc.Ready Capital to Present at Nareit’s REITweek 2024NYSE:RCReady Capital Corporation 65
2024/06/0321 : 02GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation at Upcoming Investor ConferenceNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/06/0321 : 02PR Newswire (US)MIT Sloan Management Review Research Examines Circular Business Models' Benefit to Bottom Line and Increased Sustainability Measures
2024/06/0321 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/06/0321 : 01GlobeNewswire Inc.Texas Must Close Primary Elections
2024/06/0321 : 01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RFACWRF Acquisition Corporation
2024/06/0321 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
2024/06/0321 : 01Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FUTUFutu Holdings Ltd
2024/06/0321 : 01GlobeNewswire Inc.Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024NASDAQ:MYNZMainz BioMed NV
2024/06/0321 : 01PR Newswire (US)Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesNASDAQ:AEMDAethlon Medical Inc
2024/06/0321 : 01PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - OPTI
2024/06/0321 : 00GlobeNewswire Inc.Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual MeetingTSX:MDNAMedicenna Therapeutics Corp
2024/06/0321 : 00GlobeNewswire Inc.Genesis Offers New Tools and Incentives to Financial Industry Software Developers
2024/06/0321 : 00GlobeNewswire Inc.Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease TherapiesNASDAQ:DNLIDenali Therapeutics Inc
2024/06/0321 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ZNOGWZion Oil and Gas Inc (PK)
2024/06/0321 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RFACWRF Acquisition Corporation
2024/06/0321 : 00Edgar (US Regulatory)Form 8-K - Current reportNYSE:IRTIndependence Realty Trust Inc
2024/06/0321 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FYBRFrontier Communications Parent Inc
2024/06/0321 : 00GlobeNewswire Inc.BriaCell Presents Clinical Efficacy Data at ASCO 2024NASDAQ:BCTXWBriaCell Therapeutics Corporation
2024/06/0321 : 00GlobeNewswire Inc.BriaCell Presents Clinical Efficacy Data at ASCO 2024NASDAQ:BCTXBriaCell Therapeutics Corporation
2024/06/0321 : 00GlobeNewswire Inc.BriaCell Presents Clinical Efficacy Data at ASCO 2024TSX:BCTBriaCell Therapeutics Corp
2024/06/0321 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:VLNValens Semiconductor Ltd
2024/06/0321 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
2024/06/0321 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:KULRKULR Technology Group Inc
2024/06/0321 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:BURBurford Capital Limited
2024/06/0321 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPWiPower Inc
2024/06/0321 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ALIVAutoliv Inc (PK)
2024/06/0321 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRCLStericycle Inc
2024/06/0321 : 00Business WireMcKesson’s Board of Directors Elects Deborah Dunsire as New DirectorNYSE:MCKMcKesson Corporation
2024/06/0321 : 00GlobeNewswire Inc.STMicroelectronics Announces Status of Common Share Repurchase ProgramTG:SGMST Microelectronics

最近閲覧した銘柄

Delayed Upgrade Clock